Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-887 for Kidney Disease

Albert Einstein College of Medicine awarded USD23m NIH grant to study HIV & chronic illnesses

Alnylam Completes Rolling Submission of New Drug Application to US Food and Drug Administration for Givosiran for the Treatment of Acute Hepatic Porphyria

AstraZeneca reports meeting of primary end point by Calquence phase III ELEVATE-TN trial

AstraZeneca reports detailed results of Lynparza from phase 111 POLO trial

Alnylam Doses First Patient in Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension

4D Molecular Therapeutics Presents Preclinical Data at the 6th International Update on Fabry Disease and Provides Clinical Update

KetoTV announces keto clinical trial with Nicolas Tzenios and KGK Science Inc

Merck's board approves USD0.55 per share dividend for Q3 2019

Sihuan Pharmaceutical Holdings Group Ltd wins NMPA drug registration approval for non-PVC solid-liquid double chamber bag

FDA Approves New Octaplas Product Label

FDA Approves New Octaplas Product Label

First Patient Treated in DIAMOND Study to Evaluate if Veltassa Improves Outcomes by Enabling Long-Term Use of Essential RAASi Therapy

Corvidia Therapeutics names new director

PolyPid Ltd awarded US FDA second QIDP designation for D-PLEX100 for prevention of post-abdominal surgery incisional infection